Cardiovascular Disease and the Female Disadvantage

Area of Science:

• Cardiovascular health
• Women's health
• Public health

Background:

• Cardiovascular disease (CVD) is the leading cause of death in women globally, despite traditionally being viewed as a male health issue.
• Women face significant disadvantages in CVD recognition, prevention, and treatment compared to men.
• Existing women's health research disproportionately focuses on maternal/child health and breast cancer, neglecting CVD across the female lifespan.

Purpose of the Study:

• To highlight the under-recognition and disadvantages women face regarding cardiovascular disease (CVD).
• To advocate for a broader definition of women's health research that includes CVD and other non-communicable diseases.
• To emphasize the need for sex-specific analyses in cardiovascular research.

Main Methods:

• Review of existing literature and clinical trial data on cardiovascular disease in women.
• Analysis of gender disparities in CVD risk factors, presentation, and treatment outcomes.
• Examination of current trends in women's health research funding and focus.

Main Results:

• Women experience CVD differently than men, and this is often unrecognized, leading to adverse outcomes.
• Women are undertreated in both primary and secondary CVD prevention strategies.
• Clinical trials predominantly recruit male patients, and risk factors like diabetes and smoking pose a greater proportional risk to women.

Conclusions:

• Cardiovascular disease is a critical, yet under-recognized, aspect of women's health requiring urgent attention.
• A paradigm shift is needed to redefine women's health research to encompass the entire lifespan and prioritize non-communicable diseases like CVD.
• Implementing sex-specific analyses in research is essential for advancing cardiovascular care for women.